HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilie Ducourau Selected Research

Rheumatic Diseases (Rheumatism)

6/2011Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilie Ducourau Research Topics

Disease

8Rheumatoid Arthritis
02/2015 - 01/2009
3Ankylosing Spondylitis
01/2012 - 06/2011
2Inflammation (Inflammations)
07/2014 - 06/2011
2Necrosis
07/2014 - 01/2012
1Axial Spondyloarthritis
01/2020
1Rheumatic Diseases (Rheumatism)
06/2011

Drug/Important Bio-Agent (IBA)

7Infliximab (Remicade)FDA Link
07/2014 - 01/2009
4Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 06/2011
3Adalimumab (Humira)FDA Link
01/2020 - 07/2014
3AntibodiesIBA
01/2020 - 06/2011
3Monoclonal AntibodiesIBA
07/2014 - 04/2010
2Pharmaceutical PreparationsIBA
01/2020 - 03/2012
1Biomarkers (Surrogate Marker)IBA
06/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010